Skip to content
MedsAcross

Molecule

Zinc chloride

Copper Absorption Inhibitor
Available on request
Presentations
1
Brands
0
Manufacturers
0
Available from stock
0

Zinc chloride is a copper absorption inhibitor indicated as a supplement to intravenous solutions given for total parenteral nutrition. It is available as injection for intravenous use. MedsAcross supplies Zinc chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Copper Absorption Inhibitor, Decreased Copper Ion Absorption
ATC classification
B05XA12 Zinc chloride · Blood substitutes and infusion solutions, subgroup B05X, subgroup B05XA
US FDA first approval
26 June 1986
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Intravenous
Dosage forms
Injection
Identifiers
UNII 86Q357L16BRxCUI 39937CAS 7646-85-7DrugBank DB14533Q204714

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

Zinc 1 mg/mL (Zinc Chloride Injection, USP) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. Administration helps to maintain zinc serum levels and to prevent depletion of endogenous stores, and subsequent deficiency symptoms.

Source: US FDA prescribing information

Dosing overview

Zinc 1 mg/mL (Zinc Chloride Injection, USP) contains 1 mg zinc/mL and is administered intravenously only after dilution. The additive should be diluted prior to administration in a volume of fluid not less than 100 mL. For the metabolically stable adult receiving total parenteral nutrition, the suggested intravenous dosage is 2.5 to 4 mg zinc/day (2.5 to 4 mL/day). An additional 2 mg zinc/day (2 mL/day) is suggested for acute catabolic states. For the stable adult with fluid loss from the small bowel, an additional 12.2 mg zinc/liter of small bowel fluid lost (12.2 mL/liter of small bowel fluid lost), or an additional 17.1 mg zinc/kg of stool or ileostomy output (17.1 mL/kg of stool or ileostomy output) is recommended. Frequent monitoring of zinc blood levels is suggested for patients receiving more than the usual maintenance dosage level of zinc.

Source: US FDA prescribing information

Warnings and precautions

Direct intramuscular or intravenous injection of Zinc 1 mg/mL (Zinc Chloride Injection, USP) is contraindicated as the acidic pH of the solution may cause considerable tissue irritation. Severe kidney disease may make it necessary to reduce or omit chromium and zinc doses because these elements are primarily eliminated in the urine. Copper Deficiency Several post-marketing cases have reported that zinc products taken over extended periods of time (i.e., months to years) may result in copper deficiency. The cases reported the following complications of copper deficiency: anemia, granulocytopenia, leukopenia, neutropenia, pancytopenia, thrombocytopenia, and myeloneuropathy. If a patient develops signs and/or symptoms of copper deficiency during treatment with zinc chloride, interrupt zinc treatment and check zinc and copper levels.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

1 presentations of Zinc chloride, sorted by availability.

MedicineManufacturerRegisterAvailability
Zinc chloride 10 mg/10 mL injectionIntravenousGeneric name—US FDAAvailable on request

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 26 June 1986Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Conditions

Conditions linked to Zinc chloride in public data. This is not a list of approved uses, see the clinical information.

Questions and answers

Is Zinc chloride available for export from India?

Yes, on request. MedsAcross lists 1 presentations of Zinc chloride and sources them for licensed hospitals, importers and physicians against valid import documents.

Is Zinc chloride approved by the US FDA?

Yes. The US FDA first approved Zinc chloride on 26 June 1986, according to Drugs@FDA.

Does Zinc chloride need cold chain shipping?

No listed presentation of Zinc chloride is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is Zinc chloride in?

Zinc chloride is classified under ATC code B05XA12 (Zinc chloride).

References

  1. ZINC prescribing information (Hospira). U.S. National Library of Medicine, DailyMed. Retrieved 13 May 2026

Request Zinc chloride for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.